Pacific Biosciences of California Inc (PACB)
1.465
-0.10
(-6.09%)
USD |
NASDAQ |
Apr 23, 16:00
1.48
+0.02
(+1.02%)
After-Hours: 17:40
Pacific Biosciences of California Revenue (Quarterly): 58.36M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 58.36M |
| September 30, 2023 | 55.69M |
| June 30, 2023 | 47.57M |
| March 31, 2023 | 38.90M |
| December 31, 2022 | 27.35M |
| September 30, 2022 | 32.31M |
| June 30, 2022 | 35.47M |
| March 31, 2022 | 33.17M |
| December 31, 2021 | 36.02M |
| September 30, 2021 | 34.89M |
| June 30, 2021 | 30.61M |
| March 31, 2021 | 29.00M |
| December 31, 2020 | 27.14M |
| September 30, 2020 | 19.08M |
| June 30, 2020 | 17.08M |
| March 31, 2020 | 15.60M |
| December 31, 2019 | 27.93M |
| September 30, 2019 | 21.92M |
| June 30, 2019 | 24.62M |
| March 31, 2019 | 16.42M |
| December 31, 2018 | 19.53M |
| September 30, 2018 | 18.16M |
| June 30, 2018 | 21.58M |
| March 31, 2018 | 19.36M |
| December 31, 2017 | 24.94M |
| Date | Value |
|---|---|
| September 30, 2017 | 23.54M |
| June 30, 2017 | 20.07M |
| March 31, 2017 | 24.92M |
| December 31, 2016 | 25.72M |
| September 30, 2016 | 25.12M |
| June 30, 2016 | 20.75M |
| March 31, 2016 | 19.13M |
| December 31, 2015 | 36.28M |
| September 30, 2015 | 13.92M |
| June 30, 2015 | 24.94M |
| March 31, 2015 | 17.64M |
| December 31, 2014 | 16.90M |
| September 30, 2014 | 20.62M |
| June 30, 2014 | 11.42M |
| March 31, 2014 | 11.64M |
| December 31, 2013 | 9.133M |
| September 30, 2013 | 7.421M |
| June 30, 2013 | 6.048M |
| March 31, 2013 | 5.578M |
| December 31, 2012 | 5.878M |
| September 30, 2012 | 2.776M |
| June 30, 2012 | 7.291M |
| March 31, 2012 | 10.04M |
| December 31, 2011 | 12.44M |
| September 30, 2011 | 10.52M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
15.60M
Minimum
Mar 2020
58.36M
Maximum
Dec 2023
32.25M
Average
30.61M
Median
Jun 2021
Revenue (Quarterly) Benchmarks
| Cerus Corp | 46.77M |
| Axogen Inc | 42.92M |
| AVITA Medical Inc | 14.20M |
| BioSig Technologies Inc | 0.012M |
| Intellia Therapeutics Inc | -1.917M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -82.02M |
| Total Expenses (Quarterly) | 144.74M |
| EPS Diluted (Quarterly) | -0.31 |
| Enterprise Value | 679.32M |
| Gross Profit Margin (Quarterly) | 16.40% |
| Profit Margin (Quarterly) | -140.5% |
| Earnings Yield | -82.59% |
| Normalized Earnings Yield | -75.74 |